469
Total Publications
22,195
Total Citations
Top Researchers
- William P. Newman 7,826 citations • 102 papers
- Marilyn G. Klug 4,848 citations • 135 papers
- Kimberly Hammer 1,881 citations • 49 papers
- Preston D. Steen 1,832 citations • 56 papers
- Ryan McGrath 1,671 citations • 106 papers
- Shelby A. Terstriep 1,655 citations • 23 papers
- L. Michael Howell 1,284 citations • 11 papers
- Paula Bergloff 945 citations • 16 papers
- Zeljko Jocic 844 citations • 21 papers
- Ossama M. Reslan 806 citations • 32 papers
Most Cited Papers
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study 2016 • 1,386 citations
- A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A 2016 • 484 citations
- Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations 2004 • 418 citations
- Recent warming by latitude associated with increased length of ragweed pollen season in central North America 2011 • 383 citations
- Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura 1994 • 339 citations
- Comprehensive interview assessment of eating behavior 18–35 months after gastric bypass surgery for morbid obesity 2009 • 279 citations
- Tick-Borne Relapsing Fever 2008 • 244 citations
- Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity 1996 • 239 citations
- A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival 2005 • 210 citations
- 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer 2018 • 195 citations